Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Salmen

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Fortschritte Der Neurologie-Psychiatrie|March 21, 2015
[New therapeutic options in multiple sclerosis]A Salmen, A Chan
Clinical and Experimental Immunology|December 24, 2013
Management of disease-modifying treatments in neurological autoimmune diseases of the central nervous systemA Salmen, R Gold, A Chan
Journal of Neuroimmunology|February 6, 2021
Natalizumab induced blood eosinophilia: A retrospective pharmacovigilance cohort study and review of the literatureL Diem, R Hoepner, M Bagnoud, et al.
Archives of Pediatrics & Adolescent Medicine|October 29, 1997
Childhood lead poisoning and vinyl miniblind exposureE H Norman, I Hertz-Picciotto, D A Salmen, et al.
Molecular and Cellular Probes|June 22, 2000
Identification of bacteria from a non-healing diabetic foot wound by 16 S rDNA sequencingR Redkar, J Kalns, W Butler, et al.
Multiple Sclerosis and Related Disorders|July 10, 2022
Ocrelizumab-related neutropenia: Effects of age, sex and bodyweight using the FDA Adverse Event Reporting System (FAERS)H Hammer, N Kamber, M Pistor, et al.
Multiple Sclerosis and Related Disorders|May 1, 2022
German guideline for diagnosis and treatment of multiple sclerosis - a survey focusing neurologists in daily practiseC Heesen, C Mokry, A Salmen, et al.
Multiple Sclerosis and Related Disorders|April 11, 2024
Efficacy and safety of ocrelizumab in patients with relapsing multiple sclerosis: Real-world experience of two Swiss multiple sclerosis centersL Diem, A Ovchinnikov, C Friedli, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Longitudinal analyses of anti-JCV antibody index for risk assessment of progressive multifocal leukoencephalopathyA Salmen, N von Ahsen, A K Trampe, et al.
Journal of Clinical Microbiology|May 1, 1997
A PCR assay for identification of Enterococcus faeciumS Cheng, F K McCleskey, M J Gress, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Fortschritte Der Neurologie-Psychiatrie|March 21, 2015
[New therapeutic options in multiple sclerosis]A Salmen, A Chan
Clinical and Experimental Immunology|December 24, 2013
Management of disease-modifying treatments in neurological autoimmune diseases of the central nervous systemA Salmen, R Gold, A Chan
Journal of Neuroimmunology|February 6, 2021
Natalizumab induced blood eosinophilia: A retrospective pharmacovigilance cohort study and review of the literatureL Diem, R Hoepner, M Bagnoud, et al.
Archives of Pediatrics & Adolescent Medicine|October 29, 1997
Childhood lead poisoning and vinyl miniblind exposureE H Norman, I Hertz-Picciotto, D A Salmen, et al.
Molecular and Cellular Probes|June 22, 2000
Identification of bacteria from a non-healing diabetic foot wound by 16 S rDNA sequencingR Redkar, J Kalns, W Butler, et al.
Multiple Sclerosis and Related Disorders|July 10, 2022
Ocrelizumab-related neutropenia: Effects of age, sex and bodyweight using the FDA Adverse Event Reporting System (FAERS)H Hammer, N Kamber, M Pistor, et al.
Multiple Sclerosis and Related Disorders|May 1, 2022
German guideline for diagnosis and treatment of multiple sclerosis - a survey focusing neurologists in daily practiseC Heesen, C Mokry, A Salmen, et al.
Multiple Sclerosis and Related Disorders|April 11, 2024
Efficacy and safety of ocrelizumab in patients with relapsing multiple sclerosis: Real-world experience of two Swiss multiple sclerosis centersL Diem, A Ovchinnikov, C Friedli, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Longitudinal analyses of anti-JCV antibody index for risk assessment of progressive multifocal leukoencephalopathyA Salmen, N von Ahsen, A K Trampe, et al.
Journal of Clinical Microbiology|May 1, 1997
A PCR assay for identification of Enterococcus faeciumS Cheng, F K McCleskey, M J Gress, et al.
Pageof 2